UMIN ID: UMIN000000793
Registered date:11/08/2007
Phase II study of TS-1 in elderly patients with unresectable non-small cell lung cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Non-small cell lung cancer |
| Date of first enrollment | 2007/01/01 |
| Target sample size | 32 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | TS-1 40mg/m2/day twice a day (day1-28) |
Outcome(s)
| Primary Outcome | Response rate |
|---|---|
| Secondary Outcome | Time to progression, safety, survival time |
Key inclusion & exclusion criteria
| Age minimum | 70years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1) Uncontroled pleural or pericardial effusion 2) Uncontroled brain metastasis 3) Interstitial pneumonitis, pulmonary fibrosis 4) Active infection 5) Uncontroled other disease |
Related Information
| Primary Sponsor | Nagasaki Thoracic Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Takashi Kasai |
| Address | Japan |
| Telephone | |
| naho-k@mue.biglobe.ne.jp | |
| Affiliation | Japanese Red Cross Nagasaki Atomic Bomb Hospital Internal Medicine |
| scientific contact | |
| Name | Shigeru Kohno |
| Address | 1-7-1, Sakamoto, Nagasaki, Japan Japan |
| Telephone | |
| Affiliation | Nagasaki University School of Medicine Second Department of Internal Medicine |